Purinergic Signaling in the Cardiovascular System
- PMID: 28057794
- DOI: 10.1161/CIRCRESAHA.116.309726
Purinergic Signaling in the Cardiovascular System
Abstract
There is nervous control of the heart by ATP as a cotransmitter in sympathetic, parasympathetic, and sensory-motor nerves, as well as in intracardiac neurons. Centers in the brain control heart activities and vagal cardiovascular reflexes involve purines. Adenine nucleotides and nucleosides act on purinoceptors on cardiomyocytes, AV and SA nodes, cardiac fibroblasts, and coronary blood vessels. Vascular tone is controlled by a dual mechanism. ATP, released from perivascular sympathetic nerves, causes vasoconstriction largely via P2X1 receptors. Endothelial cells release ATP in response to changes in blood flow (via shear stress) or hypoxia, to act on P2 receptors on endothelial cells to produce nitric oxide, endothelium-derived hyperpolarizing factor, or prostaglandins to cause vasodilation. ATP is also released from sensory-motor nerves during antidromic reflex activity, to produce relaxation of some blood vessels. Purinergic signaling is involved in the physiology of erythrocytes, platelets, and leukocytes. ATP is released from erythrocytes and platelets, and purinoceptors and ectonucleotidases are expressed by these cells. P1, P2Y1, P2Y12, and P2X1 receptors are expressed on platelets, which mediate platelet aggregation and shape change. Long-term (trophic) actions of purine and pyrimidine nucleosides and nucleotides promote migration and proliferation of vascular smooth muscle and endothelial cells via P1 and P2Y receptors during angiogenesis, vessel remodeling during restenosis after angioplasty and atherosclerosis. The involvement of purinergic signaling in cardiovascular pathophysiology and its therapeutic potential are discussed, including heart failure, infarction, arrhythmias, syncope, cardiomyopathy, angina, heart transplantation and coronary bypass grafts, coronary artery disease, diabetic cardiomyopathy, hypertension, ischemia, thrombosis, diabetes mellitus, and migraine.
Keywords: blood cells; blood vessels; heart failure; hypertension; thrombosis.
© 2017 American Heart Association, Inc.
Similar articles
-
Purinergic signaling and blood vessels in health and disease.Pharmacol Rev. 2013 Dec 11;66(1):102-92. doi: 10.1124/pr.113.008029. Print 2014. Pharmacol Rev. 2013. PMID: 24335194 Review.
-
Purinergic transmission in blood vessels.Auton Neurosci. 2015 Sep;191:48-66. doi: 10.1016/j.autneu.2015.04.007. Epub 2015 Apr 25. Auton Neurosci. 2015. PMID: 26004513 Review.
-
Cardiac purinergic signalling in health and disease.Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20. Purinergic Signal. 2015. PMID: 25527177 Free PMC article. Review.
-
Purinergic Signalling and Endothelium.Curr Vasc Pharmacol. 2016;14(2):130-45. doi: 10.2174/1570161114666151202204948. Curr Vasc Pharmacol. 2016. PMID: 26638799 Review.
-
Roles of P2-purinoceptors in the cardiovascular system.Circulation. 1991 Jul;84(1):1-14. doi: 10.1161/01.cir.84.1.1. Circulation. 1991. PMID: 1647896 Review.
Cited by
-
Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs.Pharmaceuticals (Basel). 2022 Dec 9;15(12):1532. doi: 10.3390/ph15121532. Pharmaceuticals (Basel). 2022. PMID: 36558983 Free PMC article. Review.
-
Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19.Life Sci. 2022 May 15;297:120482. doi: 10.1016/j.lfs.2022.120482. Epub 2022 Mar 11. Life Sci. 2022. PMID: 35288174 Free PMC article. Review.
-
Pleiotropic effects of clopidogrel.Purinergic Signal. 2022 Sep;18(3):253-265. doi: 10.1007/s11302-022-09876-0. Epub 2022 Jun 9. Purinergic Signal. 2022. PMID: 35678974 Free PMC article. Review.
-
The Pleiotropic Role of Extracellular ATP in Myocardial Remodelling.Molecules. 2023 Feb 23;28(5):2102. doi: 10.3390/molecules28052102. Molecules. 2023. PMID: 36903347 Free PMC article. Review.
-
Programmable dual responsive system reconstructing nerve interaction with small-diameter tissue-engineered vascular grafts and inhibiting intimal hyperplasia in diabetes.Bioact Mater. 2021 Jun 25;7:466-477. doi: 10.1016/j.bioactmat.2021.05.034. eCollection 2022 Jan. Bioact Mater. 2021. PMID: 34466746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources